Evidence map›Paper›PMID 39557842›Full record

ArticleNature communications2024

The role of ATP-binding Cassette subfamily B member 6 in the inner ear.

Stefanie A Baril, Katie A Wilson, Md Munan Shaik, Yu Fukuda, Robyn A Umans, Alessandro Barbieri, John Lynch, Tomoka Gose, Alexander Myasnikov, Michael L Oldham and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Stefanie A BarilDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0003-3249-2866
Katie A WilsonResearch School of Chemistry, College of Science, The Australian National University, Canberra, ACT, Australia.ORCID 0000-0002-4951-127X
Md Munan ShaikDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Yu FukudaDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0001-6182-540X
Robyn A UmansDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Alessandro BarbieriSchool of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
John LynchDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Tomoka GoseDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0003-2388-8885
Alexander MyasnikovDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0003-2607-7121
Michael L OldhamDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Yao WangDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jingwen ZhuDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jie FangDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jian ZuoDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0002-5395-2887
Ravi C KalathurDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0002-4889-8003
Robert C FordSchool of Biological Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK.
Allison CoffinDepartment of Integrative Physiology and Neuroscience, Washington State University Vancouver, Vancouver, WA, USA.
Michael R TaylorDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0003-0848-4620
Megan L O'MaraResearch School of Chemistry, College of Science, The Australian National University, Canberra, ACT, Australia.ORCID 0000-0002-8764-1585
John D SchuetzDepartment of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA. John.Schuetz@STJUDE.ORG.ORCID 0000-0003-0779-1303

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
The DNA Damage Response and Tumorigenesis in the BrainP01CA096832 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI BAKER, SUZANNE J. · 2003 to 2025
$38.0M
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrheaR01DK080834 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Anjaparavanda P Naren · 2009 to 2026
$6.8M
Transporters and MedulloblastomaR01CA194057 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SCHUETZ, JOHN D · 2015 to 2025
$4.0M
Transporters and hematopoietic toxicityR01CA194206 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SCHUETZ, JOHN D · 2016 to 2020
$2.4M
Regulation of CNS angiogenesis and barriergenesisR01NS116043 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI TAYLOR, MICHAEL ROBERT · 2020 to 2024
$1.8M
Determining the ototoxic potential of COVID-19 therapeutics using machine learning and in vivo approachesR01DC020701 · NIDCD · WASHINGTON STATE UNIVERSITY · PI ALLISON B COFFIN · 2023 to 2026
$1.6M
Characterizing the protective effects of caffeine and other natural products in aR15DC013900 · NIDCD · WASHINGTON STATE UNIVERSITY · PI COFFIN, ALLISON B · 2014 to 2015
$515k
NCI NIH HHS P01 CA096832NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA194057NCI NIH HHS R01 CA194206NIDCD NIH HHS R01 DC020701NIDCD NIH HHS R15 DC013900NIDDK NIH HHS R01 DK080834NINDS NIH HHS R01 NS116043U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01 CA194057, CA194206, P30 CA21745, CA21865, 5R01DK080834, NCI P30 CA021765, CA96832,
6 · The paper itself

Abstract

ABCB6 has been implicated in dyschromatosis universalis hereditaria, a condition characterized by hyperpigmented and hypopigmented skin macules. Dyschromatosis universalis hereditaria can also present with hearing loss. Dyschromatosis universalis hereditaria-associated mutations in ABCB6 have been reported, but the role of this protein in the inner ear has not been studied. Here we determine a high-resolution (2.93 Å) cryo-EM structure of ABCB6 and functionally characterized several dyschromatosis universalis hereditaria mutants. We find that the L356P mutant abolishes ABCB6 function, and affirm the underlying loss of ATP binding mechanism using molecular dynamics simulations based on our cryo-EM structure. To test the role of ABCB6 in the inner ear, we characterize Abcb6 (the ABCB6 homolog) in zebrafish. We show that Abcb6 suppression by morpholinos reduces inner ear and lateral line hair cell numbers. Morphants also lack the utricular otolith, which is associated with vestibular function. Co-injecting morpholinos with human ABCB6 mRNA partially rescues the morphant phenotype, suggesting that Abcb6 plays a developmental role in inner ear structures. Further, we show that Abcb6 knockout mice exhibit an increased auditory brainstem response threshold, resulting in reduced hearing sensitivity. Taken together, these data suggest ABCB6 plays a role in inner ear development and function.

Indexed as

Ear, InnerZebrafishAdenosine TriphosphateAnimalsATP-Binding Cassette TransportersCryoelectron MicroscopyHumansMiceMice, KnockoutMolecular Dynamics SimulationMutationOtolithic MembraneZebrafish ProteinsABCB6 protein, humanAdenosine TriphosphateATP-Binding Cassette TransportersZebrafish Proteins

Identifiers

PMID39557842
PMCPMC11574312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.